" class="no-js "lang="en-US"> IDTechEx Archives - Medtech Alert
Friday, March 29, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Oncology is a Major Focus for Many AI Drug Discovery Companies, Reports IDTechEx

The application of artificial intelligence (AI) in the drug discovery process is promising to drastically […]

AI in Drug Discovery Requires Extensive Chemical Libraries, Finds IDTechEx

AI in drug discovery is a field that has received an immense increase in interest, […]

Pandemic Accelerates Adoption of Electronic Skin Patches, Reports IDTechEx

Electronic skin patches represent one wearable technology product type that is well suited for physiological monitoring. […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more